Literature DB >> 9186562

Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A).

S Lociuro1, P Tavecchia, E Marzorati, P Landini, B P Goldstein, M Denaro, R Ciabatti.   

Abstract

MDL 62,879 (GE2270A) 1 is a new inhibitor of elongation factor-Tu (EF-Tu) and belongs to the class of thiazolyl peptide antibiotics. Controlled acid hydrolysis of 1 followed by treatment with base resulted in the lost of the two terminal amino acids and in the formation of water-soluble MDL 62,935 2. Although less active in vitro than its parent compound, 2 was able to inhibit by 50% an Escherichia coli cell-free protein synthesis system at roughly the same concentration of 1. MDL 62,935 2 was subjected to further modification at the beta-phenylserine residue. Derivatives obtained from 2 were less active in both antimicrobial (MIC) and enzymatic (IC50) assays. This suggests that beta-phenylserine plays an important role for the inhibition of EF-Tu by 1 and 2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186562     DOI: 10.7164/antibiotics.50.344

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

Review 1.  Thiazolyl peptide antibiotic biosynthesis: a cascade of post-translational modifications on ribosomal nascent proteins.

Authors:  Christopher T Walsh; Michael G Acker; Albert A Bowers
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

2.  In vitro antibacterial activities of a thiazolyl peptide antibiotic PM2409.

Authors:  Koteppa Pari; Girish B Mahajan; Vijayaphanikumar Yemparala; Rajendra Kshirsagar; Rajashri Parab; Prashant Shanbhag; Becky Thomas; M Manisha; Venkat Manohar; H Sivaramakrishnan
Journal:  J Antibiot (Tokyo)       Date:  2014-07-02       Impact factor: 2.649

3.  In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu.

Authors:  J A Leeds; M J LaMarche; J T Brewer; S M Bushell; G Deng; J M Dewhurst; J Dzink-Fox; E Gangl; A Jain; L Lee; M Lilly; K Manni; S Mullin; G Neckermann; C Osborne; D Palestrant; M A Patane; A Raimondi; S Ranjitkar; E M Rann; M Sachdeva; J Shao; S Tiamfook; L Whitehead; D Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.